Finasteride NDC 63187-863

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-863Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0863Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-863-20	63187086320	20 TABLET, FILM COATED in 1 BOTTLE (63187-863-20)Marketed from Feb 11, 2022
63187-863-30	63187086330	30 TABLET, FILM COATED in 1 BOTTLE (63187-863-30)Marketed from Jun 1, 2017
63187-863-60	63187086360	60 TABLET, FILM COATED in 1 BOTTLE (63187-863-60)Marketed from Jun 1, 2017
63187-863-90	63187086390	90 TABLET, FILM COATED in 1 BOTTLE (63187-863-90)Marketed from Jun 1, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Finasteride
Generic name (nonproprietary): finasteride
Active ingredients: Finasteride — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091643
Marketing start: Nov 8, 2013
Listing expires: Dec 31, 2026
Other FDA classes: 5-alpha Reductase Inhibitors (Mechanism)
Identifiers: Product ID 63187-863_fdd2ba1f-49ae-46cb-8c9c-47d2b0d659abSPL ID fdd2ba1f-49ae-46cb-8c9c-47d2b0d659abSPL set ID 870ab7fe-fff9-4348-b900-213c1cf05f8eRxCUI 200172UNII 57GNO57U7GUPC 0363187863906
Pharmacologic class: 5-alpha Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187086320 followed by a unit qualifier and the quantity

Package 63187-0863-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2022.

Indications (excerpt from the label)

Finasteride tablets are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY . Efficacy in bitemporal recession has not been established. Finasteride tablets are not indicated for use in women. • Finasteride is a 5α-reductase inhibitor indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY ( 1 ). • Finasteride tablets are not indicated for use in women ( 1 , 4 , 5.1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091643

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091643
Product	Strength	Form · route	Labeler	Product NDC
Finasteride	Finasteride 1 mg/1	Tablet, Film coatedOral	Accord Healthcare, Inc.	16729-089